BURLINGTON, Mass., Jan. 12, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced that Dr. Bobby W. Sandage, Jr., Coronado’s President and CEO, will present at the 30th Annual JP Morgan Healthcare Conference today, Thursday, January 12, 2012, at 2:00 PM PT. The conference will be held at the Westin St. Francis Hotel in San Francisco, CA.
